Table 4.
Patients with elevated α-fetoprotein (AFP) levels
| Variable | Level of AFP (ng/ml), mean (range) | Patients with AFP > 10× normal range |
|---|---|---|
| Patients with cirrhosis, n = 75 (72%) | 5835 (4-132,459) | 41 (55%) |
| Patients without cirrhosis, n = 29 (28%) | 1011 (2-20,000) | 8 (28%) |
| Alcoholic cirrhosis, n = 28 (26%) | 6495 (3-132,459) | 13 (46%) |
| HCV-positive, n = 36 (35%) | 3244 (3-56,851) | 17 (47%) |
| HBV-positive, n = 25 (24%) | 6710 (4-60,500) | 18 (72%) |
| Fatty liver disease, n = 14 (13%) | 51 (2-423) | 1 (7%) |
| Focal lesions with diameter ≤ 5 cm, n = 35 | 2149 (2-56,851) | 16 (46%) |
| Focal lesions with diameter > 5 cm, n = 69 | 5802 (3-132,459) | 31 (45%) |
| Metastatic HCC, n = 16 | 4183 (2-60,500) | 5 (31%) |
| Non-metastatic HCC, n = 88 | 4584 (2-132,459) | 44 (50%) |
| HCC with portal vein tumour thrombosis, n = 13 | 12538 (18-132,459) | 8 (62%) |
| HCC without portal vein tumour thrombosis, n = 91 | 3307 (2-60,500) | 41 (45%) |